Simcere Pharmaceutical Group Limited (2096.HK)
2096.HK Stock Price Chart
Explore Simcere Pharmaceutical Group Limited interactive price chart. Choose custom timeframes to analyze 2096.HK price movements and trends.
2096.HK Company Profile
Discover essential business fundamentals and corporate details for Simcere Pharmaceutical Group Limited (2096.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Oct 2020
Employees
6.58K
Website
https://www.simcere.comCEO
Jinsheng Ren
Description
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. The company's principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; Softan, a rosuvastatin calcium tablet; ZAILIN, an amoxicillin granules/dispersible tablet/capsule; Iremod, an iguratimod tablet; Antine, a diclofenac sodium sustained release capsule/gel; and Orencia, an abatacept injection. It also offers promotion services for pharmaceutical products. Simcere Pharmaceutical Group Limited has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize medicines targeting the neurotoxicity amyloid protein N3pE (pGlu-Aß) to treat Alzheimer's disease. The company was founded in 1995 and is headquartered in Nanjing, China.
2096.HK Financial Timeline
Browse a chronological timeline of Simcere Pharmaceutical Group Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Mar 2026
Upcoming earnings on 23 Mar 2026
Earnings released on 21 Aug 2025
EPS came in at $0.29 , while revenue for the quarter reached $3.93B .
Earnings released on 21 Aug 2025
EPS came in at $0.29 , while revenue for the quarter reached $3.93B .
Dividend declared on 18 Jun 2025
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 14 Jul 2025.
Earnings released on 23 Mar 2025
EPS came in at $0.06 , while revenue for the quarter reached $1.87B .
Earnings released on 20 Mar 2025
EPS came in at $0.06 , while revenue for the quarter reached $1.95B .
Earnings released on 22 Aug 2024
EPS came in at $0.10 , while revenue for the quarter reached $1.67B .
Dividend declared on 18 Jun 2024
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 15 Jul 2024.
Earnings released on 14 Jun 2024
EPS came in at $0.10 , while revenue for the quarter reached $1.68B .
Earnings released on 21 Mar 2024
EPS came in at -$0.33 , while revenue for the quarter reached $1.79B , missing expectations by -78.44%.
Earnings released on 30 Sept 2023
EPS came in at -$0.32 , while revenue for the quarter reached $1.73B .
Earnings released on 22 Aug 2023
EPS came in at $0.47 , while revenue for the quarter reached $1.83B , missing expectations by -76.73%.
Dividend declared on 19 Jun 2023
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 12 Jul 2023.
Earnings released on 1 Apr 2023
EPS came in at $0.19 , while revenue for the quarter reached $2.06B , missing expectations by -75.14%.
Earnings released on 31 Mar 2023
EPS came in at $0.49 , while revenue for the quarter reached $1.93B .
Earnings released on 30 Sept 2022
EPS came in at $0.18 , while revenue for the quarter reached $1.99B .
Earnings released on 1 Sept 2022
EPS came in at $0.02 , while revenue for the quarter reached $1.66B .
Earnings released on 30 Jun 2022
EPS came in at $0.01 , while revenue for the quarter reached $1.58B .
Dividend declared on 28 Jun 2022
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 15 Jul 2022.
Earnings released on 25 Mar 2022
EPS came in at $0.22 , while revenue for the quarter reached $1.74B .
Earnings released on 31 Dec 2021
EPS came in at $0.22 , while revenue for the quarter reached $1.76B .
Earnings released on 27 Aug 2021
EPS came in at $0.13 , while revenue for the quarter reached $1.26B .
Earnings released on 30 Jun 2021
EPS came in at $0.13 , while revenue for the quarter reached $1.27B .
Dividend declared on 29 Jun 2021
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 16 Jul 2021.
Earnings released on 26 Mar 2021
EPS came in at $0.12 , while revenue for the quarter reached $1.53B .
Earnings released on 28 Oct 2020
EPS came in at $0.04 , while revenue for the quarter reached $1.06B .
Earnings released on 30 Sept 2020
EPS came in at $0.11 , while revenue for the quarter reached $1.47B .
2096.HK Stock Performance
Access detailed 2096.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.